News|Articles|January 15, 2026

Therapies to Watch in 1H 2026

We highlighted a few investigational cell and gene therapy candidates to keep an eye on in the first half of the new year.

As 2026 kicks off, CGTLive® is taking a look at some of the notable investigational cell and gene therapy candidates in the pipeline. Whether they target a disease area with high unmet need, have inventive mechanisms, or are otherwise notable, here are a few of the investigational products we are keeping our eye in the first half of this year.